Tuesday, August 25, 2020

Researchers see an increase in fraudulent COVID-19 posts on social media


https://www.eurekalert.org/pub_releases/2020-08/uoc--rsa082520.php

News Release 25-Aug-2020
University of California - San Diego

During the SARS-CoV-2 pandemic, social media platforms have played a major role in conveying information from health care leaders and government officials to communities about how to help stop the spread of COVID-19. Yet as quickly as new and accurate information on the virus becomes available, so, too do counterfeit health products, such as illegal or unapproved testing kits, untested treatments and purported cures.

In a new study published in the Journal of Medical Internet Research Public Health and Surveillance on August 25, 2020, researchers at University of California San Diego School of Medicine found thousands of social media posts on two popular platforms -- Twitter and Instagram -- tied to financial scams and possible counterfeit goods specific to COVID-19 products and unapproved treatments 


•••••

Mackey provided three key tips to help identify a fraudulent post or scam:

  1. If it's too good to be true, it probably is. Look out for mentions of bulk or rapid sales, cheap pricing and questionable claims such as FDA approval or specific certifications.
  2. Importing products from another country. If you're a United States consumer, it is likely illegal to import products such as COVID-19 tests from another country. Such purchases should be considered risky.
  3. Illegitimate contact methods. If the seller is conducting business or a transaction through social media direct messages or another non-traditional communications application, including Skype or WhatsApp, it probably isn't legitimate.

"We recommend that anyone concerned of contracting COVID-19 or hoping to be tested first work with their personal health care provider or local public health agency to ensure safe access to testing or treatment, and report any suspicious activity to federal authorities," said Mackey.



•••••


No comments:

Post a Comment